anmelden
SLI
2.321,81
PKT
-15,88
PKT
-0,68
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.03.17 | Novartis buy | Kepler Cheuvreux | |
| 23.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
| 23.03.17 | Roche buy | Société Générale Group S.A. (SG) | |
| 23.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.03.17 | Roche buy | Deutsche Bank AG | |
| 23.03.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.03.17 | Holcim Neutral | UBS AG | |
| 21.03.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 21.03.17 | Swiss Re Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.03.17 | Novartis Hold | Deutsche Bank AG | |
| 17.03.17 | Nestlé buy | Goldman Sachs Group Inc. | |
| 17.03.17 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 17.03.17 | Nestlé Underperform | Macquarie Research | |
| 17.03.17 | Givaudan verkaufen | Bernstein Research | |
| 16.03.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 16.03.17 | ABB (Asea Brown Boveri) Outperform | Robert W. Baird & Co. Incorporated | |
| 15.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.03.17 | UBS overweight | JP Morgan Chase & Co. | |
| 14.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 14.03.17 | UBS Neutral | JP Morgan Chase & Co. | |
| 14.03.17 | Holcim buy | Deutsche Bank AG | |
| 14.03.17 | Novartis Neutral | UBS AG | |
| 13.03.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 10.03.17 | Novartis Hold | Deutsche Bank AG | |
| 10.03.17 | Zurich Insurance neutral | Robert W. Baird & Co. Incorporated | |
| 09.03.17 | Novartis buy | Jefferies & Company Inc. | |
| 09.03.17 | Roche buy | Jefferies & Company Inc. | |
| 08.03.17 | Novartis Underweight | Barclays Capital | |
| 08.03.17 | Roche overweight | Barclays Capital | |
| 08.03.17 | Novartis buy | Société Générale Group S.A. (SG) | |
| 08.03.17 | UBS buy | Goldman Sachs Group Inc. | |
| 08.03.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 07.03.17 | UBS buy | Citigroup Corp. | |
| 07.03.17 | Novartis Underperform | BNP PARIBAS | |
| 06.03.17 | UBS Hold | Deutsche Bank AG | |
| 06.03.17 | UBS Hold | Deutsche Bank AG | |
| 06.03.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 06.03.17 | Swiss Re Reduce | Commerzbank AG | |
| 06.03.17 | Holcim neutral | Bernstein Research |
